| Gilteritinib + daunorubicin + cytarabine for Acute myeloid leukaemia (AML) [TSID12331] | None selected | Awaiting decision | |
| Epcoritamab + R-CHOP for Diffuse large B-cell lymphoma (DLBCL) [TSID12334] | None selected | Awaiting decision | |
| Donanemab for reducing the risk of mild cognitive impairment in preclinical Alzheimer's disease [ID6675] | None selected | Awaiting decision | |
| Pozelimab with cemdisiran for treating symptomatic generalised myasthenia gravis [TSID12287] | None selected | Awaiting decision | |
| Lanadelumab for preventing recurrent attacks of hereditary angioedema in people 2 years and over [TSID12298] | None selected | Not selected | |
| Thermal Probe Ablation for abdominal wall endometriosis | None selected | Awaiting decision | |
| Vacuum Assisted Excision for the removal of breast lesions of uncertain malignant potential | None selected | Not selected | |
| Sentinel Node Biopsy approved for pathological staging of clinically T1-T2 N0 oral cancer | None selected | Not selected | |
| Mercaptamine hydrochloride for treating corneal cystine crystal deposits in people 6 months to under 2 years with cystinosis [TSID12261] | None selected | Not selected | |
| Digital flexor tenotomy for diabetic foot | None selected | Awaiting decision | |
| ID6611 Obesity, overweight - semaglutide (including review of TA875) | None selected | Awaiting decision | |
| Omental lymph node transfer for lymphoedema of the limbs | None selected | Awaiting decision | |
| Modified release hydrocortisone capsules for treating adrenal insufficiency in people 12 years and over
[TSID12254] | None selected | Not selected | |
| Dasiglucagon for treating severe hypoglycaemia caused by type 1 diabetes in people under 6 years
[TSID12255] | None selected | Not selected | |
| Semaglutide for treating type 2 diabetes in people 10 to 17 years
[TSID12249] | None selected | Not selected | |
| Male sling for stress urinary incontinence | None selected | Not selected | |
| Technologies to improve the detection of endometrial cancer | None selected | Awaiting decision | |
| Dermal allograft augmentation in proximal humerus fracture fixation | None selected | Awaiting decision | |
| Bioprosthetic or native Aortic Scallop Intentional Laceration to prevent Iatrogenic Coronary Artery obstruction (BASILICA) | None selected | Awaiting decision | |
| Hip resurfacing for hip arthritis | None selected | Awaiting decision | |
| Cryoablation for Desmoid-type Fibromatosis | None selected | Awaiting decision | |
| Transarterial radio embolisation for osteosarcoma liver metastases | None selected | Awaiting decision | |
| Ferric citrate for managing iron and serum phosphorus levels in anaemia associated with chronic kidney disease [TSID12221] | None selected | Not selected | |
| Cardiac ablation with percutaneous left atrial appendage occlusion (LAAO) for atrial fibrillation | None selected | Awaiting decision | |
| Intradiscal Platelet Rich Plasma (PRP) Injections for Back Pain with Modic Type 1 Changes | None selected | Awaiting decision | |
| Robotic surgery for paediatric population | None selected | Not selected | |
| Orbital atherectomy for calcified coronary artery disease | None selected | Not selected | |
| NeuroSAFE for Intra-operative frozen section evaluation of neurovascular bundle adjacent prostate capsule during radical prostatectomy | None selected | Awaiting decision | |
| Bioinductive collagen scaffold (Regeneten) for rotator cuf repair | None selected | Not selected | |
| Subcutaneous pembrolizumab with platinum-based chemotherapy for untreated metastatic non-small-cell lung cancer [TSID12213] | None selected | Not selected | |
| Oral cabotegravir with rilpivirine for treating HIV-1 in people 12 to 17 years [TSID12214] | None selected | Not selected | |
| Long-acting injections of cabotegravir with rilpivirine for treating HIV-1 in people 12 to 17 years [TSID12219] | None selected | Not selected | |
| Lutetium (177Lu) oxodotreotide for treating SSTR-positive advanced or inoperable gastroenteropancreatic neuroendocrine tumours in people 12 to 17 years [TSID12154] | None selected | Not selected | |
| Risankizumab for treating moderate to severe plaque psoriasis in people 6 to 17 years
[TSID12204] | None selected | Not selected | |
| Rezafungin for preventing invasive fungal infections after an allogeneic blood and marrow transplant [TSID12165] | None selected | Not selected | |
| Leniolisib for untreated activated phosphoinositide 3-kinase delta syndrome in children 4 to 11 years [TSID12190] | None selected | Not selected | |
| Zanubrutinib for Chronic lymphocytic leukaemia (CLL) or Follicular lymphoma or Marginal zone lymphoma (MZL) or Waldenstrom's macroglobulinaemia [ID12199] | None selected | Not selected | |
| Percutaneous nephrolithotomy for kidney stones greater than 1.5cm | None selected | Not selected | |
| Epicranial focal cortex stimulation for drug-resistant focal epilepsy | None selected | Not selected | |
| Excimer Laser Trabeculotomy (ELT) for glaucoma | None selected | Awaiting decision | |
| Mosunetuzumab for treating relapsed or refractory follicular lymphoma [TSID 12081] | None selected | Not selected | |
| Nifedipine - Lidocaine for Chronic Anal Fissure [TSID 12093] | None selected | Not selected | |
| Subcutaneous nivolumab–relatlimab for untreated unresectable or metastatic melanoma in people 12 years and over [TSID 12178] | None selected | Not selected | |
| Diltiazem (Anatop, SLV-324, VEN 307) for Anal fissure [TSID 12100] | None selected | Not selected | |
| Tolebrutinib for treating primary progressive multiple sclerosis [TSID12166] | None selected | Awaiting decision | |
| Dostarlimab for previously treated advanced or recurrent endometrial cancer with high microsatellite instability or mismatch repair deficiency (MA review of TA779) [ID6326] | None selected | Awaiting decision | |
| Sulthiame for treating self-limiting epilepsy with centrotemporal spikes in children TSID 12106 | None selected | Not selected | |
| Ocrelizumab for treating relapsing–remitting multiple sclerosis in people 10 to 17 years [TSID12164] | None selected | Not selected | |
| Apremilast for treating juvenile psoriatic arthritis in people 5 to 17 years [TSID12089] | None selected | Not selected | |
| Botulinum neurotoxin type E for treating moderate to severe glabellar lines [TSID12155] | None selected | Not selected | |
| Doravirine–islatravir for treating HIV-1 in people with virological suppression on antiretroviral therapy [TSID12173] | None selected | Not selected | |
| Orforglipron for treating type 2 diabetes [TSID12130] | None selected | Not selected | |
| Botulinum toxin injection to cricopharyngeal muscle for retrograde cricopharyngeal dysfunction (RCPD) | None selected | Not selected | |
| Infrared lasers for treating onychomycosis | None selected | Further information required | |
| AHEAD implants for external ear prosthesis | None selected | Not selected | |
| Doravirine–islatravir for treating HIV-1 in people with virological suppression on bictegravir, emtricitabine and tenofovir alafenamide combination treatment [TSID12171] | None selected | Not selected | |
| Doravirine-islatravir for previously untreated HIV-1 infection
[TSID12172] | None selected | Not selected | |
| Insertion of Stoma Preservation Device | None selected | Awaiting decision | |
| Intradiscal oxygen-ozone treatment of symptomatic lumbar disc herniation | None selected | Awaiting decision | |
| NEMOST growing domino for Neuromuscular early onset scoliosis with Risser 0 in first surgical intention | None selected | Awaiting decision | |
| Botulinum Toxin injection prior to Abdominal wall reconstruction | None selected | Not selected | |
| XVIVO hypothermic perfusion of the DCD heart | None selected | Not selected | |
| Spirecut's Sono-Instruments to treat carpal tunnel syndrome and trigger finger | None selected | Awaiting decision | |
| Thermocoagulation for the treatment of piles and anal fistula | None selected | Awaiting decision | |
| Veverimer for treating metabolic acidosis in chronic kidney disease [ID3832] | None selected | Awaiting decision | |
| Transoral endoscopic thyroid surgery via a vestibular approach | None selected | Not selected | |
| Transoral Endoscopic Thyroid/Parathyroid Vestibular Approach | None selected | Not selected | |
| Levodopa inhaled for patients with Parkinson's disease who experience 'off' episodes (motor response fluctuations) [TSID8778] | None selected | Not selected | |
| Linaclotide acetate for treating functional constipation in people 6 to 17 years
[TSID12125] | None selected | Not selected | |
| Vedolizumab for treating moderately to severely active ulcerative colitis in people 2 to 17 years
[TSID12134] | None selected | Not selected | |
| Eptinezumab for preventing cluster headache attacks TSID 12087 | None selected | Awaiting decision | |
| Paediatric lymphatic interventions (mainly Percutaneous thoracic duct embolisation) for Chylothorax, chylous ascites, plastic bronchitis, chylopericardium, Chyluria, Protein losing enteropathy | None selected | Not selected | |
| Multi-vessel minimal access coronary artery surgery for multi-vessel coronary artery disease | None selected | Awaiting decision | |
| High resolution anoscopy and laser therapy for intraepithelial neoplasia of the anus in high risk or immunocompromised patients | None selected | Awaiting decision | |
| Diclofenac–clotrimazole for Vulvovaginal candidiasis (VVC)
[TSID 12053] | None selected | Not selected | |
| Clindamycin for treating bacterial vaginosis in females aged 12 and older [TSID 12127] | None selected | Not selected | |
| Lebrikizumab for treating atopic dermatitis in children [TSID 12133_TSID 12135] | None selected | Not selected | |
| Ustekinumab for treating moderately to severely active ulcerative colitis in children aged 2 to 17 years [TSID 12128] | None selected | Not selected | |
| Berotralstat for preventing recurrent attacks of hereditary angioedema in children aged 2 to 12 years [TSID 12132] | None selected | Not selected | |
| Lebrikizumab for treating atopic dermatitis in children [TSID12133] | None selected | Not selected | |
| Ripretinib for treating advanced gastrointestinal stromal tumours after 3 or more treatments (review of TA881) [ID6496] | None selected | Awaiting decision | |
| Trastuzumab deruxtecan for treating HER2-positive unresectable or metastatic breast cancer after 1 or more anti-HER2 therapies (MA review TA704 and TA862) [ID5121] | None selected | Awaiting decision | |
| Avatrombopag for treating primary chronic immune thrombocytopenia in people 1 to 17 years [TSID12109] | None selected | Not selected | |
| NVK-002 for treating myopia in people 3 to 17 years [TSID11961] | None selected | Not selected | |
| Pitolisant for treating narcolepsy in children and young people 6 to 17 years ID6353 | None selected | Not selected | |
| Transbronchial lung cryobiopsy | None selected | Awaiting decision | |
| Noninvasive Vagus Nerve Stimulation For reactive airway disease | None selected | Further information required | |
| Entrectinib for treating NTRK fusion-positive solid tumours in people 1 month to 11 years [TSID12116] | None selected | Not selected | |
| Selumetinib granules for treating symptomatic and inoperable plexiform neurofibromas associated with type 1 neurofibromatosis in children 1 to 6 years [TSID12092] | None selected | Not selected | |
| Prolonged-release diazoxide choline for treating Prader-Willi syndrome [ID1389] | None selected | Awaiting decision | |
| Evinacumab for treating homozygous familial hypercholesterolemia in children aged 6 months to 11 [TSID11806] | None selected | Not selected | |
| Lomitapide for treating homozygous familial hypercholesterolaemia in people 5 to 17 years [TSID 12085] | None selected | Not selected | |
| Ustekinumab for the treatment of moderately to severely active Crohn's disease in children
[TS ID 11955] | None selected | n/a | |
| Mexiletine hydrochloride for treating myotonia in children and adolescents with myotonic disorders
[TS ID 11978] | None selected | Not selected | |
| Human normal immunoglobulin for preventing infection in chronic lymphocytic leukaemia [TSID12043] | None selected | Not selected | |
| Linaclotide acetate for treating Chronic idiopathic constipation [TSID12005] | None selected | Not selected | |
| Sumatriptan–naproxen for treating migraine-related moderate to severe headache
[TS ID 12055] | None selected | Not selected | |
| Henlius (pertuzumab biosimilar) for treating HER2-positive breast cancer [TS ID 12094] | None selected | Not selected | |
| Fetoscopic tracheal occlusion (FETO) for severe congenital diaphragmatic hernia | None selected | Further information required | |
| Budesonide–glycopyrronium–formoterol fumarate for treating severe asthma in people 12 years and over TS ID 12018 | None selected | Not selected | |
| Ferric maltol for treating iron deficiency anaemia in children and adolescents aged 1 month to 17 years
TS ID 11994 | None selected | Not selected | |
| Human immunoglobulin with recombinant human hyaluronidase for maintenance treatment of multifocal motor neuropathy in people of any age TSID 12033 | None selected | Not selected | |
| Aflibercept for untreated retinopathy in babies born preterm TS ID 11943 | None selected | Not selected | |
| Eszopiclone for treating insomnia [TSID12020] | None selected | Not selected | |
| Cefepime–enmetazobactam for treating hospital-acquired pneumonia, including ventilator-associated pneumonia TS ID 12035 | None selected | Not selected | |
| Telmisartan–amlodipine–indapamide for untreated hypertension TS ID 12034 | None selected | Not selected | |
| Human normal immunoglobulin for preventing infection in chronic lymphocytic leukaemia [TSID12043] | None selected | Not selected | |
| IgPro20 for treating dermatomyositis [TSID12014] | None selected | Not selected | |
| Subcutaneous nivolumab for treating advanced renal cell carcinoma after systemic treatment TSID 12008 | None selected | Not selected | |
| Basal insulin icodec–semaglutide for treating type 2 diabetes inadequately controlled with daily basal insulin [TSID11940] | None selected | Not selected | |
| High linear energy transfer radiation for carbon ion beam therapy | None selected | Further information required | |
| Letermovir for preventing cytomegalovirus infection in people under 18 years after allogeneic haematopoietic stem cell transplant [TS ID 11868] | None selected | Not selected | |
| Mepolizumab for treating chronic obstructive pulmonary disease with eosinophil-associated exacerbations TSID12019 | None selected | Not selected | |
| Subcutaneous amivantamab for treating advanced non-small-cell lung cancer with EGFR mutations [TSID12011] | None selected | Not selected | |
| Olorofim for treating invasive fungal infections in people 16 years and over [TSID11983] | None selected | Not selected | |
| Bismuth subcitrate potassium–metronidazole–tetracycline hydrochloride with omeprazole for treating Helicobacter pylori and preventing peptic ulcer relapse [TSID11900] | None selected | Not selected | |
| Vonicog alfa for preventing haemorrhage in people with von Willebrand disease when desmopressin is ineffective or not suitable [ID6272] | None selected | Not selected | |
| Guselkumab for treating chronic plaque psoriasis in children aged 6 to 17 years [TSID12002] | None selected | Not selected | |
| Secukinumab biosimilar for treating plaque psoriasis
[TSID11992] | None selected | Not selected | |
| Transcatheter Tricuspid Valve Replacement | None selected | Awaiting decision | |
| Ciclosporin ophthalmic solution for treating dry eyes after inadequate response to artificial tears [TSID8472] | None selected | Not selected | |
| Radiofrequency denervation for OA shoulder pain | None selected | Further information required | |
| Spinal instrumentation with robot assisted navigation | None selected | Awaiting decision | |
| Peroral endoscopic myotomy (POEM) for achalasia | None selected | Not selected | |
| Migraine trigger site deactivation surgery | None selected | Not selected | |
| Neuromodulation for chronic pelvic pain | None selected | Not selected | |
| MRI guided transurethral high intensity ultrasound ablation of the prostate | None selected | Not selected | |
| Percutaneous intraductal radiofrequency ablation for malignant biliary obstruction | None selected | Not selected | |
| Vaginal microbiota seeding for neonates | None selected | Not selected | |
| Subcutaneous isatuximab with pomalidomide and dexamethasone for treating relapsed or refractory multiple myeloma after 1 or more treatments [TSID11969] | None selected | Not selected | |
| MT547 QuickChange Incontinence Wrap for urinary incontinence
in men (MIB237) | None selected | Not selected | |
| Golimumab for treating moderately to severely active ulcerative colitis in people aged 2 to 17 years [TSID11959] | None selected | Not selected | |
| Degradable surgical implant | None selected | Not selected | |
| Deep Brain Stimulation for Alzheimer | None selected | Not selected | |
| Laparoscopic lumbar sympathectomy for foot hyperhidrosis | None selected | Not selected | |
| Transarterial Chemoembolisation for inoperable hepatocellular carcinoma | None selected | Not selected | |
| RenalGuard Therapy for reduction in the incidence of Contrast-Associated AKI (CA-AKI) in at-risk patients | None selected | Not selected | |
| Kinetic Oscillation Stimulation to the nasal cavity for the preventive treatment of adults diagnosed with chronic migraine | None selected | Awaiting decision | |
| High intensity focused ultrasound ablation for pain caused by bone metastases | None selected | Not selected | |
| The Extraperitoneal approach to left sided colorectal resections ( EXPERTS) Procedure | None selected | Awaiting decision | |
| Percutaneous transluminal radiofrequency sympathetic denervation of the renal artery for glycemic control | None selected | Not selected | |
| Low-level laser therapy (photobiomodulation) for oral neuropathic pain | None selected | Further information required | |
| Full Endoscopic Spine Surgery | None selected | Not selected | |
| Transcatheter valve-in-valve implantation for the treatment of Tricuspid valve | None selected | Awaiting decision | |
| Robotic assisted bronchoscopy | None selected | Awaiting decision | |
| Seminal Vesicle Lavage | None selected | Not selected | |
| Cutting blocks for total knee arthroplasty | None selected | Not selected | |
| MRI-guided laser interstitial thermal therapy for early prostate cancer | None selected | Not selected | |
| High Definition – transcranial Electrical Stimulation (HD-tES) for fibromyalgia | None selected | Not selected | |
| Apremilast for treating moderate to severe plaque psoriasis in people aged 6 to 17 [TSID11921] | None selected | Not selected | |
| TAK-880 for managing primary immunodeficiency diseases in people hypersensitive to IgA [TSID11883] | None selected | Not selected | |
| Ivacaftor for treating cystic fibrosis with mutations in the CFTR gene in babies and children aged 1 to 3 months or weighing 3 kg to 24 kg [TSID11894] | None selected | Not selected | |
| Spineform Hemibridge endoscopic vertebral stapling to reduce curvature in the growing scoliotic spine in children | None selected | Not selected | |
| Percutaneous Laser Ablation (PLA) for benign thyroid nodules | None selected | Not selected | |
| Electromagnetic stimulation to promote healing of non-union fractures | None selected | Not selected | |
| Percutaneous cryotherapy (PCT) for the therapy of primary lung cancer or metastatic lung cancer | None selected | Not selected | |
| Helium plasma coagulation for treating Respiratory Papillomatosis | None selected | Not selected | |
| Endoscopic ultrasound guided radiofrequency ablation (EUS-RFA) system for pancreatic cystic neoplasms and neuroendocrine tumours | None selected | Not selected | |
| Cipaglucosidase alfa with miglustat for treating late-onset Pompe disease in people 12 to 17 years [TSID11887] | None selected | Not selected | |
| Dapsone for treating COVID 19 in people 40 years and over with high-risk comorbidity and people 70 years and over [TSID11892] | None selected | Not selected | |
| Subcutaneous ocrelizumab for treating primary progressive or relapsing multiple sclerosis [TSID11895] | None selected | Not selected | |
| Electrosurgery (diathermy and coblation) for tonsillectomy | None selected | Not selected | |
| Transnasal Panendoscopy | None selected | Awaiting decision | |
| Arthrosamid for symptomatic treatment of knee osteoarthritis | None selected | Not selected | |
| Electrosurgery (diathermy and coblation) for tonsillectomy, (IP324/2) | None selected | Not selected | |
| Implantable Vagus Nerve Stimulator in Heart Failure | None selected | Not selected | |
| Subcutaneous C1-esterase inhibitor for preventing recurrent attacks of hereditary angioedema in people 12 years and over [TSID11891] | None selected | Not selected | |
| Meniscal Allograft Transplantation for symptomatic meniscal deficient knee | None selected | Not selected | |
| Extracorporeal bioartificial liver assist therapy | None selected | Not selected | |
| Inserting a bupivicaine-collagen implant into a surgical wound for postoperative analgesia | None selected | Not selected | |
| An aortic cuff counterpulsation system for the treatment of heart failure | None selected | Not selected | |
| Use of a glue or sealant to achieve lung volume reduction in emphysema and lung cancer | None selected | Not selected | |
| Chemical Component Separation | None selected | Not selected | |
| Intralesional cryotherapy for keloid scars | None selected | Awaiting decision | |
| LIVERFASt for diagnosing and staging liver injury and chronic liver disease, (MT783) | None selected | Not selected | |
| iQoro neuromuscular training device, (MT809) | None selected | Not selected | |
| Spectra Optia for plasma exchange, (MT828) | None selected | Not selected | |
| BPMpathway for rehabilitation support in joint replacement surgery, (MIB319) | None selected | Not selected | |
| Extracorporeal shockwave therapy for refractory plantar fasciitis | None selected | Further information required | |
| Endoscopic ultrasound guided gastro-jejunostomy (EUS GJ) | None selected | Awaiting decision | |
| Lenacapavir for treating multidrug resistant HIV-1 [ID6196] | None selected | Not selected | |
| Phalloplasty | None selected | Not selected | |
| Transvenous embolisation of cranial Arteriovenous Malformation | None selected | Not selected | |
| Urolon, (MT821) | None selected | Not selected | |
| Jada, (MT826) | None selected | Not selected | |
| Hysteroscopic proximal tubal cannulation | None selected | Not selected | |
| Transnasal endoscopy | None selected | Not selected | |
| Radiofrequency ablation of the basivertebral nerve for chronic low back pain | None selected | Not selected | |
| Hysteroscopic metroplasty of a uterine septum for recurrent miscarriage | None selected | Further information required | |
| Spinal Cord Stimulation Effective for HIV Neuropathy | None selected | Not selected | |
| Bariatric left gastric artery embolisation | None selected | Not selected | |
| External stimulation of the auricular branch of the vagus nerve | None selected | Not selected | |
| Central arteriovenous anastomosis for the treatment of patients with uncontrolled hypertension | None selected | Not selected | |
| Remedē System (Respicardia Inc) for transvenous stimulation of the phrenic nerve towards the tehrapy of Central sleep apnoea - moderate to severe | None selected | Not selected | |
| Echolaser for BPH | None selected | Not selected | |
| Avtozma (tocilizumab biosimilar) for treating moderate to severe rheumatoid arthritis in people aged 18 to 75 [TSID11848] | None selected | Not selected | |
| Selective internal radiation therapy for unresectable colorectal metastases in the liver | None selected | Not selected | |
| Setmelanotide for treating obesity caused by a rare genetic disorder in children aged 2 to 5 [TSID11827] | None selected | Not selected | |
| Elexacaftor–tezacaftor–ivacaftor and ivacaftor for treating cystic fibrosis with at least 1 F508del mutation in the CFTR gene in children aged 2 to 5 [TSID10767] | None selected | Not selected | |
| Lateral orbital decompression | None selected | Not selected | |
| Coronary venous arterialisation in patients with refractory angina | None selected | Not selected | |
| Perfusion-induced systemic hyperthermia for the treatment of advanced lung cancer | None selected | Not selected | |
| Endovascular Arch Repair | None selected | Not selected | |
| Innovative treatment of leakage and anastomotic insufficiency | None selected | Awaiting decision | |
| Subcutaneous ravulizumab for treating paroxysmal nocturnal haemoglobinuria or atypical haemolytic uraemic syndrome [TSID11820] | None selected | Not selected | |
| CT-P39 (omalizumab biosimilar) for previously treated chronic spontaneous urticaria [TSID11832] | None selected | Not selected | |
| Semaglutide for treating obesity-related heart failure with preserved ejection fraction [TSID11788] | None selected | Not selected | |
| Subcutaneous efgartigmod for treating generalised myasthenia gravis [TSID11835] | None selected | Not selected | |
| NPJ5008 for treating malignant hyperthermia [TSID11829] | None selected | Not selected | |
| PromarkerD for predicting the risk of diabetic kidney disease in people with type 2 diabetes, (MT740) | None selected | Not selected | |
| Ambu aScope 4 Broncho for routine diagnostic and therapeutic bronchoscopy, (MT158) | None selected | Not selected | |
| Intravenous infusion of mesenchymal stromal cells in patients with severe recalcitrant psoriasis | None selected | Not selected | |
| Advanced Pelvic Exenteration surgery for complex pelvic cancers | None selected | Not selected | |
| Magnetic compression anastomosis for rectal atresia | None selected | Further information required | |
| Vascular Robotics | None selected | Not selected | |
| Extradural motor cortex stimulation (EMCS) for Parkinson's disease | None selected | Further information required | |
| Focused Electrohydraulic Shockwaves for wound healing | None selected | Not selected | |
| Bronchoscopic intrabullous autologous blood instillation (BIABI) for the therapy of Emphysema: intractable with pneumothorax, COPD & Lung cancer, patients requiring lung biopsy | None selected | Not selected | |
| Intravenous infusion of mesenchymal stromal cells in patients with severe recalcitrant psoriasis | None selected | Not selected | |
| Emicizumab for preventing bleeding episodes in people with mild or moderate haemophilia A [ID5098] | None selected | Not selected | |
| Baricitinib for treating moderate to severe atopic dermatitis in children and young people aged 2 to 17 [TSID10639] | None selected | Not selected | |
| Ceftobiprole medocaril for treating community- or hospital-acquired pneumonia in people 3 months to 17 years [TSID11819] | None selected | Not selected | |
| Subcutaneous belimumab for treating systemic lupus erythematosus in children aged 5 to 17 [TSID11828] | None selected | Not selected | |
| EUS guided portal pressure measurement | None selected | Awaiting decision | |
| Bardoxolone methyl for treating chronic kidney disease in people 12 years and over with Alport syndrome [TSID9998] | None selected | Not selected | |
| Aflibercept for untreated diabetic macular oedema [TSID10621] | None selected | Not selected | |
| High-dose aflibercept for treating wet age-related macular degeneration [TSID10590] | None selected | Not selected | |
| High intensity focused electromagnetic (HIFEM) energy to target the pelvic floor muscles | None selected | Not selected | |
| Transcranial direct current stimulation (tDCS) for the treatment of refractory epilepsy | None selected | Further information required | |
| Semaglutide for treating type 2 diabetes and associated peripheral arterial disease [TSID11791] | None selected | Not selected | |
| Percutaneous Laser (Photo) Ablation of Liver Tumours | None selected | Awaiting decision | |
| Stockholm3 blood test for prostate cancer, (MT734), | None selected | Not selected | |
| Glucarpidase for reducing toxic plasma methotrexate levels in people aged 28 days and over [TSID10761] | None selected | Not selected | |
| Sacubitril valsartan for treating chronic heart failure with reduced ejection fraction in people under 18 years [TSID10350] | None selected | Not selected | |
| Circcurer Circumcision | None selected | Not selected | |
| Advanced pelvic exenteration / high complexity pelvic exenteration | None selected | Awaiting decision | |
| Macitentan for treating pulmonary arterial hypertension in people 1 month to 17 years [TSID11805] | None selected | Not selected | |
| O2Matic pro 100 (MT746) | None selected | Not selected | |
| Signatera molecular residual disease assay (MT741) | None selected | Not selected | |
| ABP-654 (ustekinumab biosimilar) for previously treated moderate to severe plaque psoriasis [TSID11790] | None selected | Not selected | |
| DV7103 for treating cystinuria in people 6 months and over [TSID10438] | None selected | Further information required | |
| Polydioxanone stents for the therapy of Tracheal stenosis: adults | None selected | Awaiting decision | |
| Treprostinil for treating symptomatic chronic thromboembolic pulmonary hypertension [ID3926 ] | None selected | Not selected | |
| Canakinumab for untreated Schnitzler syndrome [ID4063] | None selected | Not selected | |
| Gender Affirmation Surgery: Masculinising - Metoidioplasty | None selected | Not selected | |
| Teduglutide for treating short bowel syndrome in babies 4 to 12 months
[TSID10755] | None selected | Not selected | |
| EchoLaser percutaneous laser ablation treatment for patients with neck lesions | None selected | Not selected | |
| Crizanlizumab for preventing recurrent vaso-occlusive crises in sickle cell disease in young people aged 12 to 17 [TSID10766] | None selected | Not selected | |
| Differential Target Multiplexed Spinal Cord Stimulation (MT742) | None selected | Not selected | |
| Transcutaneous electrical stimulation of the upper airway dilator muscles for obstructive sleep apnoea | None selected | Further information required | |
| Mechanical Thrombectomy for PE | None selected | n/a | |
| Needle Muscle Biopsy | None selected | Not selected | |
| CT-P43 (ustekinumab biosimilar) for treating moderate to severe plaque psoriasis [TSID11773] | None selected | Not selected | |
| Minimally invasive surgical evacuation of intracerebral haemorrhage using endoscopic assisted clot aspiration | None selected | Not selected | |
| Electrocautery cutting balloon treatment for pelviureteric junction obstruction | None selected | Not selected | |
| Endovascular stent insertion for intracranial atherosclerotic disease | None selected | Further information required | |
| Percutaneous electrothermal treatment of the intervertebral disc annulus for low back pain and sciatica | None selected | Further information required | |
| Image-guided high intensity focused ultrasound to treat breast cancer | None selected | Not selected | |
| Fasciotens | None selected | Not selected | |
| Hyaluronic acid injection in periprosthetic leakage / pharyngocutaneous fistula in patients with voice prosthesis in post-laryngectomy patients | None selected | Not selected | |
| Dimethyl fumarate for treating relapsing-remitting multiple sclerosis in people aged 13 to 17 [TSID11778] | None selected | Not selected | |
| Riluzole oral film for treating amyotrophic lateral sclerosis [TSID11779] | None selected | Not selected | |
| Respirasense | None selected | Not selected | |
| Cyanoacrylate glue for hernia mesh fixation | None selected | Not selected | |
| Natalizumab for treating highly active relapsing-remitting multiple sclerosis [ID4020] | None selected | Not selected | |
| Cyanoacrylate glue for hernia mesh fixation (MT707) | None selected | Not selected | |
| RespiraSense (MT736) | None selected | Not selected | |
| Rezafungin for untreated invasive candidiasis [TSID10768] | None selected | Not selected | |
| HealthVCF for detecting vertebral compression fractures on CT scans MT581 (MIB267) | None selected | Not selected | |
| Levodopa, carbidopa monohydrate and entacapone intestinal gel for treating the symptoms of advanced Parkinson's disease [ID4005] | None selected | Not selected | |
| Plasma surgical laser ablation for vulval intraepithelial neoplasia | None selected | Not selected | |
| Ultrasound-guided high-intensity transcutaneous focused ultrasound for symptomatic uterine fibroids | None selected | Further information required | |
| Trans-septal transcatheter mitral valve-in-valve implantation for failed surgical mitral valve bioprosthesis | None selected | Further information required | |
| ABP 959 (eculizumab biosimilar) for treating paroxysmal nocturnal haemoglobinuria [TSID10250] | None selected | Not selected | |
| Macitentant–tadalafil for treating pulmonary arterial hypertension [TSID10517] | None selected | Not selected | |
| eXroid for internal haemorrhoids | None selected | Not selected | |
| Parathyroid autofluorescence and parathyroid angiography | None selected | Not selected | |
| Pancreas SABR | None selected | Not selected | |
| Balloon dilation plus spiculiform electrosurgery towards the therapy of obstructive Airway Disease: Central Airway Fibrotic Stricture - benign | None selected | Not selected | |
| Dulaglutide for treating type 2 diabetes in children and young people [TSID10660] | None selected | Not selected | |
| Bladder EpiCheck for the detection of bladder cancer recurrence (MT706) | None selected | Further information required | |
| Electrically-stimulated intravesical chemotherapy for non-muscle invasive bladder cancer | None selected | Further information required | |
| Thromboaspiration for Intermediate risk Pulmonary Embolism | None selected | Not selected | |
| Capsule endoscopy for oesophageal disease | None selected | Not selected | |
| Lymphatico-venous anastomosis for chronic lymphoedema | None selected | Not selected | |
| Dupilumab for children with severe atopic dermatitis [TSID10434] | None selected | Not selected | |
| Lumella Pre-Eclampsia Test (MT687) | None selected | Not selected | |
| TUC Safety Valve to prevent balloon inflation in the urethra during transurethral catheterisation (MT512) | None selected | Not selected | |
| TUC Safety Valve to prevent balloon inflation in the urethra during transurethral catheterisation (MT512) | None selected | Not selected | |
| Lumella Pre-Eclampsia point-of-care test for assessing pre-eclampsia risk (MT687) | None selected | Not selected | |
| d-NAV for optimization of personal insulin management in adults with type 2 diabetes (MT696) | None selected | Not selected | |
| The Insides System chyme reinfusion system (MT682) | None selected | Not selected | |
| Emtricitabine/tenofovir alafenamide for human immunodeficiency virus type-1 infection [TSID10723] | None selected | Not selected | |
| Darunavir plus cobicistat fixed dose combination for paediatric human immunodeficiency virus 1 infection [TSID10722] | None selected | Not selected | |
| Prostate specific membrane antigen (PSMA) radiotherapy for treating advanced prostate cancer | None selected | Not selected | |
| Glatiramer acetate depot for multiple sclerosis [TSID10620] | None selected | Further information required | |
| Crizotinib for treating ALK-positive anaplastic large cell lymphoma or inflammatory myofibroblastic tumour in people 6 to 17 years [TSID10574] | None selected | Not selected | |
| Naviswiss navigation for total hip replacement | None selected | Not selected | |
| MemoKath Stent Insertion | None selected | Not selected | |
| BioTime's Premvia HyStem hydrogel for the management of a wide range of wounds | None selected | Not selected | |
| Dupilumab for maintenance treatment of uncontrolled moderate to severe asthma in children 6 to 11 years [TSID10085] | None selected | Not selected | |
| MT684 Smart Peak Flow for monitoring asthma | None selected | Not selected | |
| MT658 Quit Genius for Smoking Cessation | None selected | Not selected | |
| Baloxavir marboxil for treating and preventing influenza in children 1 to 11 years [ID6554] | None selected | Further information required | |
| MT656 Paige Prostate AI system for the detection of prostate cancer | None selected | Not selected | |
| MT660 CerebAir for monitoring continuous, real-time EEG | None selected | Not selected | |
| MT650 24/7 EEG SubQ for people with epilepsy | None selected | Not selected | |
| MT633 FreeO2 Automatic Oxygen Titration | None selected | Not selected | |
| CADScor system for ruling out coronary artery disease in people with symptoms of stable coronary artery disease (MT434 | None selected | Not selected | |
| MT646 Bardy Carnation Ambulatory Monitor | None selected | Not selected | |
| CADScor system for ruling out coronary artery disease in people with symptoms of stable coronary artery disease (MT434 | None selected | Not selected | |
| Stereotactic anterior cingulotomy for intractable pain | None selected | Not selected | |
| Non-Invasive Fat Reduction and Body Contouring | None selected | Not selected | |
| Use of oesophageal warming device ensoETM to maintain temperature | None selected | Not selected | |
| Botulinum injection of abdominal wall prior to massive incisional hernia repair | None selected | Not selected | |
| Oesophageal String Test | None selected | Not selected | |
| Imbio CT lung texture analysis for identifying interstitial lung disease (MT618) (MIB272) | None selected | Not selected | |
| PLASMA system for electrovaporisation of the prostate (MT597) (MIB274) | None selected | Not selected | |
| Colli-pee void urine collection device (MT628) (MIB273) | None selected | Not selected | |
| trublood-prostate for triaging and diagnosing people with prostate cancer symptoms (MT604) (MIB268) | None selected | Not selected | |
| MMprofiler for prognostic risk classification in multiple myeloma (MT623) (MIB270) | None selected | Not selected | |
| Magtrace/Sentimag MT599 (MIB263) | None selected | n/a | |
| AI in retinal scanning MT524 (MIB265) | None selected | Not selected | |
| Acumen IQ sensor MT616 (MIB266) | None selected | Not selected | |
| CT guided fibrin glue sealing of CSF leak to treat spontaneous intracranial hypotension | None selected | Not selected | |
| Syne Covid for predicting COVID 19 outcomes MT655 | None selected | Not selected | |
| Kodex EPD system MT575 (MIB260) | None selected | Not selected | |
| MTEP - Routing Butterfly IQ ultrasound scanner MT635 (MIB254) | None selected | Not selected | |
| RenalSense Clarity RMS for acute kidney injury MT601 (MIB256) | None selected | Not selected | |
| PROPEL (mometasone furoate implant, 370ug) MT578 (MIB253) | None selected | Not selected | |
| microINR for anticoagulation therapy MT592 (MIB257) | None selected | Not selected | |
| Woundexpress MT602 (MIB261) | None selected | Not selected | |
| Natural Cycles for monitoring fertility | None selected | Not selected | |
| DOASENSE DOAC dipstick product for the detection of direct oral anti-coagulants | None selected | Not selected | |
| CytoSorb for reducing risk of bleeding during cardiac surgery | None selected | Not selected | |
| Moor LDLS-BI for assessing burn depth and healing potential in children and adults | None selected | Not selected | |
| The Stak for knee stretching following knee replacement or injury or to treat osteoarthritis | None selected | Not selected | |
| URO17 for testing suspected bladder cancer | None selected | Not selected | |
| Lonafarnib for treating progeria and progeroid laminopathies [ID3867] | None selected | Not selected | |
| Liposomal bupivacaine for treating postoperative pain [ID3799] | None selected | Not selected | |
| Zoll ThermoGuard XP for Intravascular Temperature Management | None selected | Not selected | |
| Accuro handheld ultrasound device for locating intervertebral space for administration of spinal anaesthesia | None selected | Not selected | |
| Remimazolam for general anaesthesia [ID3796] | None selected | Not selected | |
| Remimazolam for sedation for people having diagnostic or therapeutic procedures [ID3758] | None selected | Not selected | |
| Healthy.io test for home testing of urine albumin to creatinine ratio | None selected | Not selected | |
| FebriDx for C-reactive protein and myxovirus resistance protein A testing | None selected | Not selected | |
| Helge for detecting haemolysis | None selected | Not selected | |
| Spartan RX point-of-care CYP2C19 test | None selected | Not selected | |
| Miniature lens system implantation for advanced age-related macular degeneration | None selected | Further information required | |
| CFHealthHub for managing cystic fibrosis during the COVID 19 pandemic | None selected | Not selected | |
| Archimedes for biopsy of suspected lung cancer | None selected | Not selected | |
| Actim Pancreatitis for diagnosing acute pancreatitis | None selected | Awaiting decision | |
| PCONUS2 Bifurcation Aneurysm Implant for complex intracranial aneurysms | None selected | Not selected | |
| MolecuLight i:X for wound imaging | None selected | Not selected | |
| Nitisinone for treating alkaptonuria [ID2691] | None selected | Not selected | |
| Cor-Knot for tying suture knots in valve surgery | None selected | Not selected | |
| TUC Safety Valve to prevent balloon inflation in the urethra during transurethral catheterisation | None selected | Not selected | |
| Cytokine adsorption technologies for treating respiratory failure in people with COVID 19 | None selected | Not selected | |
| NATROX oxygen wound therapy for managing diabetic foot ulcers and complex or chronic non-healing wounds | None selected | Not selected | |
| Automated percutaneous mechanical lumbar discectomy | None selected | Further information required | |
| Intravascular Lithotripsy-Enabled Vascular Access for Transfemoral Transcatheter Aortic Valve Replacement | None selected | Not selected | |
| Single-incision short sling mesh insertion for stress urinary incontinence in women | None selected | Further information required | |
| Insertion of a synthetic cartilage for first CMC osteoarthritis | None selected | Further information required | |
| Fingolimod for treating relapsing multiple sclerosis in children and young people [ID1378] | None selected | Not selected | |
| Autologous unmanipulated peripheral blood stem cell therapy for multiple sclerosis | None selected | Further information required | |
| Cervical ripening ballon for the induction of labour in women who have previously undergone cesarean section | None selected | Not selected | |
| Paclitaxel + XR17 (Paclical) with carboplatin for ovarian cancer [TSID5462] | None selected | Not selected | |
| Fibreoptic endoscopic evaluation of swallowing (FEES) | None selected | Not selected | |
| Atezolizumab with cabozantinib for treating metastatic non-small-cell lung cancer after platinum-based chemotherapy and 1 PD-L1 checkpoint inhibitor TSID 11812 | None selected | n/a | TBC |
| TVB-009 (denosumab biosimilar) for treating postmenopausal osteoporosis in people aged 60 to 90 [TSID11807] | None selected | Not selected | TBC |
| Abilify MyCite for treating bipolar disorder 1 or schizophrenia [ID3833] | None selected | Awaiting decision | TBC |
| Minimally invasive meshless and dissectionless anchoring system for pelvic organ prolapse repair | None selected | Awaiting decision | TBC |
| Sternoclavicular joint replacement for arthritis | None selected | Awaiting decision | TBC |